Le Lézard
Classified in: Health
Subjects: PDT, SVY

CooperRiis Introduces Supported Education Program


ASHEVILLE, N.C., Nov. 13, 2019 /PRNewswire/ -- CooperRiis, a residential healing community for individuals with mental health challenges, has established a new program for residents wanting to pursue college-level education while in treatment.

The College Program at CooperRiis integrates residential mental health treatment with specialized services designed to help residents achieve success in their college experience. The new initiative enhances the CooperRiis mission to provide personalized care that combines evidence-based clinical interventions, community work & service, education, and integrative wellness practices.

"We're so pleased to offer this exciting new program to our residents," said Eric A. Levine, Ed.D., President & CEO at CooperRiis. "Through this initiative, residents can return to school, or go for the first time, with the support of a team of professionals focused on helping them succeed."

Levine has a doctorate in education leadership and more than 30 years of experience developing educational programming and helping young people with emotional and behavioral disabilities find appropriate support services.

Studies show a rise in mental health issues on the nation's college campuses. The American Psychiatric Association found that in 2017 about 34 percent of students were being treated for a mental health issue, compared to 19 percent of students in 2007. The National Alliance on Mental Illness (NAMI) reports that one in four young adults, ages 18-24, have a diagnosable mental illness.

Residents participating in The College Program at CooperRiis receive an individualized recovery plan that includes specific supported education goals. Each resident is assigned a Recovery Team, which monitors treatment progress and determines when the resident is ready to enroll in school. The Recovery Team includes a psychiatrist, therapist, recovery coordinator and supported education coach.

Once a resident is enrolled, the education coach collaborates with the college to develop and implement a supported education plan. The coach works with the resident throughout the semester providing services including weekly educational coaching sessions, on-site intervention and mentoring, crisis support, and skills development.

Based at the CooperRiis campus in Asheville, NC, the new program will provide supported education services at three area colleges. For more, contact Kim Nelson, National Outreach Coordinator, at (828) 817-3783 or [email protected].

Founded in 2003, CooperRiis serves individuals, ages 18 and up, struggling with social-emotional issues and mental illness, including anxiety, depression, bipolar disorder, schizophrenia, addiction and substance use, in supportive residential settings and community group homes.

www.cooperriis.org/supported-college-program/ 

CONTACT:

Eric A. Levine, CooperRiis President & CEO


(828) 899-4673 or [email protected]

SOURCE CooperRiis


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: